Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

Clinical trial NCT01460693 · COMPLETED

Trial details

NCT number: NCT01460693
Sponsor: Newcastle University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myeloid Leukemia, Chronic, Chronic Phase

Start date: 2008-08-01
Primary completion: 2018-03-07
Enrollment: 814

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.